Initial dietary and microbiological environments deviate in normal-weight compared to overweight children at 10 years of age

Journal of Pediatric Gastroenterology and Nutrition

Volumn 52, Issue 1, 2011, Pages 90-95

  Luoto, Raakel ^a   Kalliomäki, Marko ^a   Laitinen, Kirsi ^b   Delzenne, Nathalie M ^c   Cani, Patrice D ^c   Salminen, Seppo ^b   Isolauri, Erika ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

adiponectin; bifidobacteria; gut microbiota; obesity; overweight; sCD14

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD14 ANTIGEN; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN;

ARTICLE; BACTERIAL COUNT; BIFIDOBACTERIUM; CHILD; CHILD NUTRITION; COHORT ANALYSIS; COLOSTRUM; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; INFANT; INFLAMMATION; INTESTINE FLORA; MALE; METABOLISM; OBESITY; PRIORITY JOURNAL;

ACUTE-PHASE PROTEINS; ADIPONECTIN; ANTIGENS, CD14; BACTERIAL LOAD; BIFIDOBACTERIUM; BODY MASS INDEX; C-REACTIVE PROTEIN; CARRIER PROTEINS; COLOSTRUM; FECES; FEMALE; GASTROINTESTINAL TRACT; HUMANS; IDEAL BODY WEIGHT; INFANT; LIPOPOLYSACCHARIDES; MALE; MEMBRANE GLYCOPROTEINS; OVERWEIGHT; PREGNANCY; RECEPTORS, PATTERN RECOGNITION; RISK FACTORS;

EID: 78650944916     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181f3457f     Document Type: Article

References (35)

1. International Obesity Task Force. Obesity rates, by country and gender. Available at: .
2. Reilly JJ, Methven E, McDowell ZC, et al. Health consequences of obesity. Arch Dis Child 2003;88:748-52.
3. Parsons TJ, Power C, Manor O. Fetal and early life growth and body mass index from birth to early adulthood in 1958 British cohort: longitudinal study. BMJ 2001;323:1331-5.
4. McCarthy A, Hughes R, Tilling K, et al. Birth weight; postnatal, infant, and childhood growth; and obesity in young adulthood: evidence from the Barry Caerphilly Growth Study. Am J Clin Nutr 2007;86:907-13.
5. Mackie RI, Sghir A, Gaskins HR. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 1999;69:1035-45.
6. Kalliomäki M, Collado MC, Salminen S, et al. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr 2008;87:534-8.
7. Bäckhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004;101:15718-23.
8. Cani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008;57: 1470-81.
9. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007;56:1761-72.
10. Collado MC, Isolauri E, Laitinen K, et al. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr 2008;88:894-9.
11. Grönlund M.M. Gueimonde M. Laitinen K. et al.. Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clin Exp Allergy 2007;37:1764-72.
12. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005;115:911-9.
13. Okamoto Y, Kihara S, Funahashi T, et al. Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci 2006;110:267-78.
14. Tsatsanis C, Zacharioudaki V, Androulidaki A, et al. Peripheral factors in the metabolic syndrome: the pivotal role of adiponectin. Ann N Y Acad Sci 2006;1083:185-95.
15. Li S, Shin JJ, Ding EL, et al. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2009; 302:179-88.
16. Kalliomäki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001;357:1076-9.
17. Cole TJ, Bellizzi MC, Flegal KM, et al. Establishing a standard definition for children overweight and obesity: international survey. BMJ 2000;320:1240-6.
18. Semple RK, Soos MA, Luan J, et al. Elevated plasma adiponectin in humans with genetically defective insulin receptors. J Clin Endocrinol Metab 2006;91:3219-23.
19. Weyermann M, Brenner H, Rothenbacher D. Adipokines in human milk and risk of overweight in early childhood: a prospective cohort study. Epidemiology 2007;18:722-9.
20. Woo JG, Guerrero ML, Altaye M, et al. Human milk adiponectin is associated with infant growth in two independent cohorts. Breastfeed Med 2009;4:101-9.
21. Savino F, Petrucci E, Nanni G. Adiponectin: an intriguing hormone for paediatricians. Acta Paediatr 2008;97:701-5.
22. Yamaguchi N, Argueta JG, Masuhiro Y, et al. Adiponectin inhibits Tolllike receptor family-induced signaling. FEBS Lett 2005;579:6821-6.
23. McFarlin BK, Johnston CA, Tyler C, et al. Inflammatory markers are elevated in overweight Mexican-American children. Int J Pediatr Obes 2007;2:235-41.
24. Tsatsanis C, Zacharioudaki V, Androulidaki A, et al. Adiponectin induces TNF-a and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli. Biochem Biophys Res Commun 2005;335:1254-63.
25. Turner JJ, Smolinska MJ, Sacre SM, et al. Induction of TLR tolerance in human macrophages by adiponectin: does LPS play a role? Scand J Immunol 2009;69:329-36.
26. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microbicidal proteins involved in innate immunity. Cell 2004;118:229-41.
27. Laitinen K, Hoppu U, Hämäläinen M, et al. Breast milk fatty acids may link innate and adaptive immune regulation: analysis of soluble CD14, prostaglandin E2 and fatty acids. Pediatr Res 2006;59:723-7.
28. Kitchens RL, Thompson PA. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J Endotoxin Res 2005;11:225-9.
29. Turnbaugh PJ, Gordon JI. The core gut microbiome, energy balance and obesity. J Physiol 2009;587(Pt 17):4153-8.
30. Wang Z, Xiao G, Yao Y, et al. The role of Bifidobacteria in gut barrier function after thermal injury in rats. J Trauma 2006;61:650-7.
31. Cani PD, Neyrinck AM, Fava F, et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007;50:2374-83.
32. Sjögren YM, Tomicic S, Lundberg A, et al. Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses. Clin Exp Allergy 2009;39:1842-51.
33. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009;9:313-23.
34. Lemieux I, Pascot A, Prudhomme D, et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 2001;21:961-7.
35. Noble A. Do we have a memory of danger as well as antigen? Trends Immunol 2009;30:150-6.